Literature DB >> 9215679

Mutations in the Chediak-Higashi syndrome gene (CHS1) indicate requirement for the complete 3801 amino acid CHS protein.

M A Karim1, D L Nagle, H H Kandil, J Bürger, K J Moore, R A Spritz.   

Abstract

Chediak-Higashi syndrome (CHS) is a rare, usually fatal, autosomal recessive disorder characterized by severe immunologic defects, reduced pigmentation, progressive neurologic dysfunction and a bleeding diathesis. The hallmark of CHS is giant organelles and giant granules in many different cell types, most likely the result of defective trafficking of specific organellar and granular proteins necessary for the normal genesis, structure or function of these cytoplasmic components. The CHS1 gene has recently been identified and shown to be homologous to the beige locus of the mouse; however, there has been disagreement as to the length of the functional CHS1 mRNA and protein. Here we report homozygous CHS1 gene mutations in two of the original probands we used to map the gene to 1q42-q44. One of these, a frameshift at codon 3197, supports our assertion that the functional CHS protein is a predicted 3801 amino acid polypeptide encoded by a 13.5 kb mRNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9215679     DOI: 10.1093/hmg/6.7.1087

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  14 in total

1.  Chediak-Higashi syndrome.

Authors:  P Kumar; K S Rao; P Shashikala; H R Chandrashekar; C R Banapurmath
Journal:  Indian J Pediatr       Date:  2000-08       Impact factor: 1.967

2.  Crystal structure of the BEACH domain reveals an unusual fold and extensive association with a novel PH domain.

Authors:  Gerwald Jogl; Yang Shen; Damara Gebauer; Jiang Li; Katja Wiegmann; Hamid Kashkar; Martin Krönke; Liang Tong
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

3.  Chediak-Higashi syndrome with early developmental delay resulting from paternal heterodisomy of chromosome 1.

Authors:  Irini Manoli; Gretchen Golas; Wendy Westbroek; Thierry Vilboux; Thomas C Markello; Wendy Introne; Dawn Maynard; Ben Pederson; Ekaterini Tsilou; Michael B Jordan; P Suzanne Hart; James G White; William A Gahl; Marjan Huizing
Journal:  Am J Med Genet A       Date:  2010-06       Impact factor: 2.802

4.  A novel mutation in the cathepsin C gene in a Pakistani family with Papillon-Lefevre syndrome.

Authors:  M Kurban; T Cheng; M Wajid; M Kiuru; Y Shimomura; A M Christiano
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-03-04       Impact factor: 6.166

Review 5.  Genetic defects in Chediak-Higashi syndrome and the beige mouse.

Authors:  R A Spritz
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

6.  Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs.

Authors:  Yvonne Mica; Gabsang Lee; Stuart M Chambers; Mark J Tomishima; Lorenz Studer
Journal:  Cell Rep       Date:  2013-04-11       Impact factor: 9.423

7.  Grey, a novel mutation in the murine Lyst gene, causes the beige phenotype by skipping of exon 25.

Authors:  Fabian Runkel; Heinrich Büssow; Kevin L Seburn; Gregory A Cox; Diane McVey Ward; Jerry Kaplan; Thomas Franz
Journal:  Mamm Genome       Date:  2006-03-03       Impact factor: 2.957

8.  Aspirin: pharmacology and clinical applications.

Authors:  Enma V Paez Espinosa; John P Murad; Fadi T Khasawneh
Journal:  Thrombosis       Date:  2011-11-17

Review 9.  Towards the targeted management of Chediak-Higashi syndrome.

Authors:  Maria L Lozano; Jose Rivera; Isabel Sánchez-Guiu; Vicente Vicente
Journal:  Orphanet J Rare Dis       Date:  2014-08-18       Impact factor: 4.123

10.  Unlocking the Molecular Secrete(s) of α-Granule Biogenesis.

Authors:  Leila J Noetzli; Joseph E Italiano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 10.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.